MedPath

Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

Completed
Conditions
Non-small Cell Lung Cancer
Extensive Disease Small Cell Lung Cancer
Registration Number
NCT04501497
Lead Sponsor
Chugai Pharmaceutical
Brief Summary

This is a multi-center observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer(NSCLC) or extensive disease small cell lung cancer(ED-SCLC). 800 patients in NSCLC cohort and 400 patients in ED-SCLC cohort will be enrolled in this trial to assess the efficacy and safety of this combination.

Detailed Description

Primary endpoint: 12 months OS, Secondary endpoints: Overall Survival(OS), 6 months survival rate(6mo OS), 12 months survival rate(12mo OS), Progression-Free Survival(PFS), Time to treatment failure (TTF), Objective Response Rate(ORR), Disease Control Rate(DCR), Duration of Response(DOR) ,Safety and Comprehensive geriatric assessment(G8)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1221
Inclusion Criteria

< non-small cell lung cancer cohort>

  1. Patients 20 years of age or older at the time of signed consent.
  2. Patients with unresectable, advanced and recurrent non-small cell lung cancer.
  3. Patients who are scheduled to start atezolizumab combination therapy in clinical practice, based on the atezolizumab package insert and the Optimal Use Promotion Guideline.
  4. Patients who signed informed consent form before enrolling the study. The consent from a legally acceptable representative is required for the patients with uncertain capacity of judgments.

<extensive disease small cell lung cancer cohort>

  1. Patients 20 years of age or older at the time of signed consent.
  2. Patients with extensive disease small cell lung cancer.
  3. Patients who are scheduled to start atezolizumab combination therapy in clinical practice, based on the atezolizumab package insert and the Optimal Use Promotion Guideline.
  4. Patients who signed informed consent form before enrolling the study. The consent from a legally acceptable representative is required for the patients with uncertain capacity of judgments.
Exclusion Criteria

< non-small cell lung cancer cohort> (1) Patients who are unsuitable for enrolment into the study by the investigator's judgment.

<extensive disease small cell lung cancer cohort>

(1) Patients who are unsuitable for enrolment into the study by the investigator's judgment.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
12 months survival rateBaseline up to 12 Months

Percentage of participants alive 12 months after initiation of treatment

Secondary Outcome Measures
NameTimeMethod
Overall SurvivalUp to death (up to 3 years)

OS was defined as the time from the first day of study treatment to death due to any cause

6 moths survival rateUp to 6 months

Percentage of participants alive 6 months after initiation of treatment

18 moths survival rateUp to 18 months

Percentage of participants alive 18 months after initiation of treatment

Progression-Free Survival(PFS)Up to disease progression or death whichever occurs first (up to 3 years)

PFS based on disease status as evaluated by the investigator in accordance with Response Evaluation Criteria in Solid Tumors (RECIST), Version 1.1 (v1.1)

Time to treatment failure (TTF)Up to 3 years

TTF was defined as the time from the first day of study treatment to treatment discontinuation for any reason, including disease progression, treatment toxicity, patient preference, or death

Post-treatment transfer rateUp to post-treatment is started (up to 3 years)

Rate of patients who received drug therapy for primary disease after study treatment

Objective Response Rate(ORR)Up to disease progression or death whichever occurs first (up to 3 years)

Percentage of participants with objective response as assessed by the investigator according to RECIST v1.1

Duration of Response(DOR)From date of first objective response up to disease progression or death whichever occurs first (up to 3 years)

Duration of Response as Assessed by the Investigator According to RECIST v1.1

Disease Control Rate(DCR)Up to 3 years

Percentage of patients with controled disease as Assessed by the investigator according to RECIST v1.1

Percentage of Participants with adverse events(Adverse Reactions)Up to 3 years

The incidence of worst-grade adverse events on study as graded by NCI-CTCAE v5.0

Comprehensive geriatric assessment (G8)At baseline

The G-8 screening tool was developed to identify elderly cancer patients who would benefit from comprehensive geriatric assessment

Trial Locations

Locations (148)

Akashi Medical Center

🇯🇵

Akashi, Japan

National Hospital Organization Asahikawa Medical Center

🇯🇵

Asahikawa, Japan

Nippon Medical School Hospital

🇯🇵

Bunkyō-Ku, Japan

Juntendo University Hospital

🇯🇵

Bunkyō-Ku, Japan

Hyogo Cancer Center

🇯🇵

Akashi, Japan

Tokyo Medical And Dental University, Medical Hospital

🇯🇵

Bunkyō-Ku, Japan

Chiba University Hospital

🇯🇵

Chiba, Japan

Fujisawa City Hospital

🇯🇵

Fujisawa, Japan

National Cancer Center Hospital

🇯🇵

Chuo Ku, Japan

Fukui Prefectural Hospital

🇯🇵

Fukui, Japan

Hamamatsu University Hospital

🇯🇵

Hamamatsu, Japan

Japanese Red Cross Ise Hospital

🇯🇵

Ise, Japan

Itami City Hospital

🇯🇵

Itami, Japan

Juntendo University Shizuoka Hospital

🇯🇵

Izunokuni, Japan

Kameda Medical Center

🇯🇵

Kamogawa, Japan

Ishikawa Prefectural Central Hospital

🇯🇵

Kanazawa, Japan

Kanazawa University Hospital

🇯🇵

Kanazawa, Japan

Ibaraki Prefectural Central Hospital

🇯🇵

Kasama, Japan

Kasukabe Medical Center

🇯🇵

Kasukabe, Japan

Japan Anti-Tuberculosis Association Fukujuji Hospital

🇯🇵

Kiyose, Japan

National Hospital Organization Tokyo National Hospital

🇯🇵

Kiyose, Japan

Kishiwada City Hospital

🇯🇵

Kishiwada, Japan

Japan Community Health care Organization Kyushu Hospital

🇯🇵

Kitakyushu, Japan

Hospital of the University of Occupational and Envioronmental Health

🇯🇵

Kitakyushu, Japan

Kobe City Medical Center General Hospital

🇯🇵

Kobe, Japan

Dokkyo Medical University Saitama Medical Center

🇯🇵

Koshigaya, Japan

The Cancer Institute Hospital of Japanese Foundation For Cancer Research

🇯🇵

Koto-Ku, Japan

National Hospital Organization Kure Medical Center and Chugoku Cancer

🇯🇵

Kure, Japan

Kobe University Hospital

🇯🇵

Kobe, Japan

Kurashiki Central Hospital

🇯🇵

Kurashiki, Japan

Kurume University Hospital

🇯🇵

Kurume, Japan

Kyoto City Hospital

🇯🇵

Kyoto, Japan

University Hospital, Kyoto Prefectural University of Medicine

🇯🇵

Kyoto, Japan

Shinshu University Hospital

🇯🇵

Matsumoto, Japan

Kyoto University Hospital

🇯🇵

Kyoto, Japan

Kyoto-Katsura Hospital

🇯🇵

Kyoto, Japan

National Hospital Organization Shikoku Cancer Center

🇯🇵

Matsuyama, Japan

National Hospital Organization Tokyo Medical Center

🇯🇵

Meguro-Ku, Japan

The Jikei University Hospital

🇯🇵

Minato-Ku, Japan

Miyazaki Prefectural Miyazaki Hospital

🇯🇵

Miyazaki, Japan

Nagahama City Hospital

🇯🇵

Nagahama, Japan

Aichi Medical University Hospital

🇯🇵

Nagakute, Japan

Nagoya Ekisaikai Hospital

🇯🇵

Nagoya, Japan

Miyagi Cancer Center

🇯🇵

Natori, Japan

The Hospital of Hyogo College of Medicine

🇯🇵

Nishinomiya, Japan

Saga University Hospital

🇯🇵

Saga, Japan

National Hospital Organization Kinki-Chuo Chest Medical Center

🇯🇵

Sakai, Japan

Japanese Red Cross Okayama Hospital

🇯🇵

Okayama, Japan

Okayama Rosai Hospital

🇯🇵

Okayama, Japan

Osaka Saiseikai Nakatsu Hospital

🇯🇵

Osaka, Japan

Osaka City General Hospital

🇯🇵

Osaka, Japan

Osaka General Medical Center

🇯🇵

Osaka, Japan

Osaka International Cancer Institute

🇯🇵

Osaka, Japan

Osaki Citizen Hospital

🇯🇵

Osaki, Japan

Jichi Medical University Saitama Medical Center

🇯🇵

Saitama, Japan

Hokkaido University Hospital

🇯🇵

Sapporo, Japan

Saitama Prefectural Cancer Center

🇯🇵

Saitama, Japan

Saitama Red Cross Hospital

🇯🇵

Saitama, Japan

Center Hospital of the National Center for Global Health and Medicine

🇯🇵

Shinjuku-Ku, Japan

Sapporo Medical University Hospital

🇯🇵

Sapporo, Japan

Jichi Medical University Hospital

🇯🇵

Shimotsuke, Japan

Keio University Hospital

🇯🇵

Shinjuku-Ku, Japan

Tohoku Medical And Pharmaceutical University Hospital

🇯🇵

Sendai, Japan

Saiseikai Suita Hospital

🇯🇵

Suita, Japan

Osaka Medical and Pharmaceutical University Hospital

🇯🇵

Takatsuki, Japan

Tenri Hospital

🇯🇵

Tenri, Japan

Tsukuba Medical Center Hospital

🇯🇵

Tsukuba, Japan

Fujita Health University Hospital

🇯🇵

Toyoake, Japan

National Hospital Organization Osaka Toneyama Medical Center

🇯🇵

Toyonaka, Japan

TOYOTA Memorial Hospital

🇯🇵

Toyota, Japan

Wakayama Medical University Hospital

🇯🇵

Wakayama, Japan

University of Tsukuba Hospital

🇯🇵

Tsukuba, Japan

National Hospital Organization Yamaguchi-Ube Medical Center

🇯🇵

Ube, Japan

Japanese Red Cross Wakayama Medical Center

🇯🇵

Wakayama, Japan

Juntendo University Urayasu Hospital

🇯🇵

Urayasu, Japan

Yokosuka Kyosai Hospital

🇯🇵

Yokosuka, Japan

Kanagawa Cancer Center

🇯🇵

Yokohama, Japan

Ogaki Municipal Hospital

🇯🇵

Ōgaki, Japan

Tottori University Hospital

🇯🇵

Yonago, Japan

Yokohama City University Hospital

🇯🇵

Yokohama, Japan

Oita University Hospital

🇯🇵

Yufu, Japan

Gunma Prefectural Cancer Center

🇯🇵

Ōta, Japan

Shiga University of Medical Science Hospital

🇯🇵

Ōtsu, Japan

Kyushu University Hospital

🇯🇵

Fukuoka, Japan

National Hospital Organization Kyushu Medical Center

🇯🇵

Fukuoka, Japan

Fukushima Medical University Hospital

🇯🇵

Fukushima, Japan

National Hospital Organization Kyushu Cancer Center

🇯🇵

Fukuoka, Japan

Kagawa University Hospital

🇯🇵

Kagawa, Japan

Gifu Prefectural General Medical Center

🇯🇵

Gifu, Japan

National Hospital Organization Okinawa National Hospital

🇯🇵

Ginowan, Japan

National Hospital Organization Himeji Medical Center

🇯🇵

Himeji, Japan

Hirosaki University Hospital

🇯🇵

Hirosaki, Japan

Kansai Medical University Hospital

🇯🇵

Hirakata, Japan

Hiroshima University Hospital

🇯🇵

Hiroshima, Japan

Aso Iizuka Hospital

🇯🇵

Iizuka, Japan

National Hospital Organization Iwakuni Clinical Center

🇯🇵

Iwakuni, Japan

Teikyo University Hospital

🇯🇵

Itabashi-Ku, Japan

Shimane University Hospital

🇯🇵

Izumo, Japan

Tokai University Hospital

🇯🇵

Isehara, Japan

Kagoshima University Hospital

🇯🇵

Kagoshima, Japan

Kitakyushu Municipal Medical Center

🇯🇵

Kitakyushu, Japan

Matsusaka Municipal Hospital

🇯🇵

Matsusaka, Japan

National Hospital Organization Kyoto Medical Center

🇯🇵

Kyoto, Japan

Tokyo Saiseikai Central Hospital

🇯🇵

Minato-Ku, Japan

Aichi Cancer Center

🇯🇵

Nagoya, Japan

Nagasaki University Hospital

🇯🇵

Nagasaki, Japan

Japanese Red Cross Nagoya Daini Hospital

🇯🇵

Nagoya, Japan

Nagoya University Hospital

🇯🇵

Nagoya, Japan

Niigata University Medical and Dental Hospital

🇯🇵

Niigata, Japan

Obihiro Kosei Hospital

🇯🇵

Obihiro, Japan

Kawasaki Medical School General Medical Center

🇯🇵

Okayama, Japan

Okayama University Hospital

🇯🇵

Okayama, Japan

Kitasato University Hospital

🇯🇵

Sagamihara, Japan

Saitama medical university International medical Center

🇯🇵

Saitama, Japan

National Hospital Organization Hokkaido Cancer Center

🇯🇵

Sapporo, Japan

Teine Keijinkai Hospital

🇯🇵

Sapporo, Japan

Sendai Kousei Hospital

🇯🇵

Sendai, Japan

Showa University Hospital

🇯🇵

Shinagawa-Ku, Japan

Iwate Medical University Hospital

🇯🇵

Shiwa-gun, Japan

Osaka University Hospital

🇯🇵

Suita, Japan

Shizuoka Cancer Center

🇯🇵

Shizuoka, Japan

Toyama Prefectural Central Hospital

🇯🇵

Toyama, Japan

Oita Prefectural Hospital

🇯🇵

Ōita, Japan

National Hospital Organization Nagoya Medical Center

🇯🇵

Nagoya, Japan

Niigata Cancer Center Hospital

🇯🇵

Niigata, Japan

Asahikawa Medical University Hospital

🇯🇵

Asahikawa, Japan

Hyogo Prefectural Amagasaki General Medical Center

🇯🇵

Amagasaki, Japan

Hiroshima City Hiroshima Citizens Hospital

🇯🇵

Hiroshima, Japan

Hiroshima Prefectural Hospital

🇯🇵

Hiroshima, Japan

Nippon Medical School Chiba Hokusoh Hospital

🇯🇵

Inzai, Japan

Fukuoka University Hospital

🇯🇵

Fukuoka, Japan

Kobe Minimally Invasive Cancer Center

🇯🇵

Kobe, Japan

Kyorin University Hospital

🇯🇵

Mitaka, Japan

Nagoya City University Hospital

🇯🇵

Nagoya, Japan

Tokushima University Hospital

🇯🇵

Tokushima, Japan

Tohoku University Hospital

🇯🇵

Sendai, Japan

Dokkyo Medical University Hospital

🇯🇵

Tochigi, Japan

Japanese Red Cross Medical Center

🇯🇵

Shibuya-Ku, Japan

Tokyo Medical University Hospital

🇯🇵

Shinjuku-Ku, Japan

JA Toyama Kouseiren Takaoka Hospital

🇯🇵

Takaoka, Japan

Shizuoka General Hospital

🇯🇵

Shizuoka, Japan

Kagawa Prefectural Central Hospital

🇯🇵

Takamatsu, Japan

Takarazuka City Hospital

🇯🇵

Takarazuka, Japan

Tokushima Prefectural Central Hospital

🇯🇵

Tokushima, Japan

Kanagawa Cardiovascular and Respiratory Center

🇯🇵

Yokohama, Japan

Ehime University Hospital

🇯🇵

Tōon, Japan

Kindai University Hospital

🇯🇵

Ōsaka-sayama, Japan

Yokohama Municipal Citizen's Hospital

🇯🇵

Yokohama, Japan

© Copyright 2025. All Rights Reserved by MedPath